EFFICACY OF COMBINED LEVOTHYROXINE AND LIOTHYRONINE AS COMPARED WITH LEVOTHYROXINE MONOTHERAPY IN PRIMARY HYPOTHYROIDISM: A RANDOMIZED CONTROLLED TRIAL

被引:52
|
作者
Valizadeh, Majid [2 ]
Seyyed-Majidi, Mohammad R. [2 ]
Hajibeigloo, Hasan [2 ]
Momtazi, Saeed [3 ]
Musavinasab, Noreddin [4 ]
Hayatbakhsh, Mohammad R. [1 ]
机构
[1] Univ Queensland, Sch Populat Hlth, Herston, Qld 4006, Australia
[2] Zanjan Univ Med Sci, Zanjan Fac Med, Dept Internal Med, Zanjan, Iran
[3] Zanjan Univ Med Sci, Zanjan Fac Med, Dept Psychol, Zanjan, Iran
[4] Zanjan Univ Med Sci, Zanjan Fac Med, Dept Stat, Zanjan, Iran
关键词
Primary Hypothyroidism; Combination Therapy; Levothyroxine Monotherapy; QUALITY-OF-LIFE; REPLACEMENT THERAPY; CLINICAL HYPOTHYROIDISM; PLUS TRIIODOTHYRONINE; SCALED VERSION; L-THYROXINE; COMMUNITY; HEALTH; EUTHYROIDISM; TISSUES;
D O I
10.1080/07435800903156340
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To examine the efficacy of combination therapy with levothyroxine and liothyronine in improvement of general health, psychological problems, and metabolic status in primary hypothyroidism. Methods. Seventy-one patients diagnosed with primary hypothyroidism were randomly allocated into two study groups: the first group received usual dose of levothyroxine and the second group received combination of levothyroxine and liothyronine for at least 4 months. The main outcomes were psychosocial problems (Goldberg's General Health Questionnaire, GHQ-28), bodyweight, heart. rate, blood Pressure, and serum lipid levels. Results. In both groups serum thyroid-stimulating hormone levels remained unchanged compared with baseline. Psychosocial scores, body weight, heart rate, blood pressure, and lipid profile in the two groups remained constant. The only exception was a small but significant reduction. in anxiety/insomnia in combined treatment group as compared with monotherapy. Conclusions. The data do not support the hypothesis that combined therapy improves the well-being and general health of Patients.
引用
收藏
页码:80 / 89
页数:10
相关论文
共 50 条
  • [41] Concomitant Use of Levothyroxine and Proton Pump Inhibitors in Patients with Primary Hypothyroidism: a Systematic Review
    Guzman-Prado, Yuli
    Vita, Roberto
    Samson, Ondrej
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (06) : 1726 - 1733
  • [42] Levothyroxine replacement in primary congenital hypothyroidism: the higher the initial dose the higher the rate of overtreatment
    Tuhan, Hale
    Abaci, Ayhan
    Cicek, Gizem
    Anik, Ahmet
    Catli, Gonul
    Demir, Korcan
    Bober, Ece
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2016, 29 (02) : 133 - 138
  • [43] Effect of timing of levothyroxine administration on the treatment of hypothyroidism: a three-period crossover randomized study
    Skelin, Marko
    Lucijanic, Tomo
    Liberati-Cizmek, Ana-Marija
    Klobucar, Sanja Majanovic
    Lucijanic, Marko
    Jakupovic, Lejsa
    Bakula, Miro
    Loncar, Jelena Vucak
    Marusic, Srecko
    Matic, Tomas
    Romic, Zeljko
    Dumic, Jerka
    Rahelic, Dario
    ENDOCRINE, 2018, 62 (02) : 432 - 439
  • [44] Study protocol: a randomised controlled trial on the clinical effects of levothyroxine treatment for subclinical hypothyroidism in people aged 80 years and over
    R. S. Du Puy
    I. Postmus
    D. J. Stott
    M. R. Blum
    R. K. E. Poortvliet
    W. P. J. Den Elzen
    R. P. Peeters
    B. C. van Munster
    B. H. R. Wolffenbuttel
    R. G. J. Westendorp
    P. M. Kearney
    I. Ford
    S. Kean
    C. M. Messow
    T. Watt
    J. W. Jukema
    O. M. Dekkers
    J. W. A. Smit
    N. Rodondi
    J. Gussekloo
    S. P. Mooijaart
    BMC Endocrine Disorders, 18
  • [45] Study protocol: a randomised controlled trial on the clinical effects of levothyroxine treatment for subclinical hypothyroidism in people aged 80 years and over
    Du Puy, R. S.
    Postmus, I
    Stott, D. J.
    Blum, M. R.
    Poortvliet, R. K. E.
    Den Elzen, W. P. J.
    Peeters, R. P.
    van Munster, B. C.
    Wolffenbuttel, B. H. R.
    Westendorp, R. G. J.
    Kearney, P. M.
    Ford, I
    Kean, S.
    Messow, C. M.
    Watt, T.
    Jukemal, J. W.
    Dekkers, O. M.
    Smit, J. W. A.
    Rodondi, N.
    Gussekloo, J.
    Mooijaart, S. P.
    BMC ENDOCRINE DISORDERS, 2018, 18
  • [46] Add on effect of Whole System Ayurveda protocol in suboptimal controlled Primary Hypothyroidism - A randomized controlled trial
    Vivek
    Chougale, Arun
    Joshi, Himanshu
    Tubaki, Basavaraj R.
    JOURNAL OF AYURVEDA AND INTEGRATIVE MEDICINE, 2025, 16 (01)
  • [47] Severity of Fatigue and Its Relationship with TSH before and after Levothyroxine Replacement Therapy in Patients with Primary Hypothyroidism
    Ruiz-Pacheco, Maria Guadalupe
    Hernandez, Irma
    Hernandez-Estrella, Guadalupe
    Basurto, Lourdes
    Vargas-Ortega, Guadalupe
    Gonzalez-Virla, Baldomero
    Molina-Ayala, Mario
    Hernandez-Martinez, Alex Francisco
    Luengas-Mondragon, Rosamaria
    Hernandez-Allende, Angel Alejandro
    Mendoza-Zubieta, Victoria
    Balcazar-Hernandez, Lourdes
    BIOMEDICINES, 2023, 11 (03)
  • [48] Effects of discontinuation of levothyroxine treatment in older adults: protocol for a self-controlled trial
    Ravensberg, A. Janneke
    Poortvliet, Rosalinde K. E.
    Du Puy, Robert S.
    Dekkers, Olaf M.
    Mooijaart, Simon P.
    Gussekloo, Jacobijn
    BMJ OPEN, 2023, 13 (04):
  • [49] Clinical, behavioural and pharmacogenomic factors influencing the response to levothyroxine therapy in patients with primary hypothyroidism—protocol for a systematic review
    Rosie Dew
    Onyebuchi Okosieme
    Colin Dayan
    Vinay Eligar
    Ishrat Khan
    Salman Razvi
    Simon Pearce
    Scott Wilkes
    Systematic Reviews, 6
  • [50] Age-Related Serum Thyroid-Stimulating Hormone Reference Range in Older Patients Treated with Levothyroxine: A Randomized Controlled Feasibility Trial (SORTED 1)
    Razvi, Salman
    Ryan, Vicky
    Ingoe, Lorna
    Pearce, SimonH.
    Wilkes, Scott
    EUROPEAN THYROID JOURNAL, 2020, 9 (01) : 40 - 48